Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 1.533 Q1 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | 35.97 | |
2 | Current Molecular Pharmacology | journal | 1.419 Q1 | 49 | 18 | 77 | 1656 | 261 | 69 | 2.78 | 92.00 | 38.64 | |
3 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | 33.48 | |
4 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | 39.76 | |
5 | Current Medicinal Chemistry | journal | 1.282 Q1 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | 39.63 | |
6 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | 39.57 | |
7 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | 38.01 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.963 Q2 | 108 | 144 | 409 | 11251 | 1144 | 375 | 2.65 | 78.13 | 40.47 | |
9 | Journal of Toxicology | journal | 0.890 Q2 | 47 | 33 | 135 | 1508 | 435 | 131 | 2.68 | 45.70 | 32.31 | |
10 | Current Vascular Pharmacology | journal | 0.828 Q2 | 69 | 109 | 275 | 9714 | 772 | 247 | 2.46 | 89.12 | 37.10 | |
11 | Infectious Disorders - Drug Targets | journal | 0.808 Q2 | 61 | 33 | 133 | 1828 | 251 | 120 | 1.72 | 55.39 | 36.52 | |
12 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 Q2 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | 45.98 | |
13 | Open Medicinal Chemistry Journal | journal | 0.743 Q2 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | 38.46 | |
14 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.660 Q2 | 45 | 33 | 67 | 2056 | 110 | 62 | 1.78 | 62.30 | 40.00 | |
15 | Current Radiopharmaceuticals | journal | 0.589 Q2 | 32 | 20 | 111 | 651 | 193 | 103 | 1.75 | 32.55 | 41.76 | |
16 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.532 Q3 | 43 | 26 | 99 | 1555 | 137 | 92 | 1.21 | 59.81 | 33.33 | |
17 | Reviews on Recent Clinical Trials | journal | 0.520 Q3 | 35 | 40 | 93 | 2503 | 152 | 87 | 1.60 | 62.58 | 35.71 | |
18 | Records of Natural Products | journal | 0.469 Q3 | 41 | 61 | 158 | 1453 | 239 | 158 | 1.17 | 23.82 | 39.38 | |
19 | Current Drug Safety | journal | 0.424 Q3 | 41 | 35 | 159 | 1681 | 252 | 149 | 1.42 | 48.03 | 42.76 | |
20 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.274 Q3 | 27 | 24 | 100 | 910 | 91 | 88 | 1.31 | 37.92 | 32.20 | |
21 | Journal of Medicinal Plants | journal | 0.245 Q3 | 27 | 55 | 214 | 1689 | 97 | 214 | 0.39 | 30.71 | 37.24 | |
22 | Current Pharmacogenomics and Personalized Medicine | journal | 0.220 Q3 | 20 | 16 | 109 | 867 | 84 | 86 | 0.62 | 54.19 | 41.18 | |
23 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.206 Q3 | 17 | 18 | 94 | 683 | 42 | 88 | 0.34 | 37.94 | 41.94 | |
24 | Anti-Infective Agents | journal | 0.174 Q4 | 26 | 21 | 42 | 1038 | 21 | 40 | 0.50 | 49.43 | 41.67 | |
25 | Iranian Journal of Pharmacology and Therapeutics | journal | 0.160 Q4 | 24 | 8 | 35 | 198 | 13 | 35 | 0.32 | 24.75 | 45.45 | |
26 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.154 Q4 | 10 | 9 | 38 | 344 | 11 | 38 | 0.17 | 38.22 | 46.15 | |
27 | Physiology and Pharmacology (Iran) | journal | 0.148 Q4 | 15 | 45 | 147 | 1654 | 38 | 145 | 0.30 | 36.76 | 45.83 | |
28 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 13 | 6 | 0 | 346 | 0 | 0 | 0.00 | 57.67 | 50.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®